Assembly and targeting of adaptin chimeras in transfected cells by unknown
Assembly and Targeting of Adaptin Chimeras in Transfected Cells 
Margaret S. Robinson 
Department of Clinical Biochemistry,  University  of  Cambridge, Addenbrookes  Hospital, Hills Road, 
Cambridge CB2 2QR, England 
Abstract.  Adaptors are the components of clathrin- 
coated pits and vesicles that attach the clathrin to the 
membrane. There are two types of adaptors in the 
cell: one associated with the plasma membrane and 
one associated with the TGN.  Both adaptors are hetero- 
tetramers consisting of two adaptins (or and/3 for the 
plasma membrane; 3~ and/3' for the TGN), plus two 
smaller proteins.  The COOH-terminal domains of the 
adaptins form appendages that resemble ears, con- 
nected by flexible hinges.  Unlike the other adaptor 
components, the COOH termini of the c~- and 3,-adap- 
tins show no homology with each other, suggesting 
that they might provide the signal that directs the 
adaptors to the appropriate membrane. To test this 
possibility, the COOH-terminal ears were switched be- 
tween or- and 3,-adaptins  and were also deleted. All of 
the constructs contained the bovine "y-adaptin hinge, 
enabling them to be detected with a species-specific 
antibody against this region when transfected into rat 
fibroblasts.  Immunoprecipitation indicated that the 
engineered adaptins were still fully capable of  assembling 
into adaptor complexes. Immunofluorescence revealed 
that in spite of their modified ears, the constructs were 
still able to be recruited onto the appropriate mem- 
brane; however, the ear-minus constructs gave in- 
creased cytoplasmic staining, and replacing the 
qr-adaptin ear with the a-adaptin ear caused a small 
amount of colocalization with endogenous ct-adaptin  in 
some cells.  Thus, the major targeting determinant ap- 
pears to reside in the adaptor "head" while the ears 
may stabilize the association of adaptors with the 
membrane. 
APa'INS are proteins  of ,,o100 kD which are associ- 
ated with clathrin-coated  vesicles.  There are three 
classes of adaptins: ct,/$, and 3'. In the cell, adaptins 
interact with other proteins to form heterotetrameric protein 
complexes known as adaptors,  consisting of one/3-adaptin 
subunit, one a- or 3,-adaptin subunit, one medium chain of 
,,050 kD (AP50 or AP47), and one small chain of •  20 kD 
(AP17 or AP19) (see Pearse and Robinson, 1990; Robinson, 
1992). Two types of adaptors have been identified, one as- 
sociated with the plasma membrane and one associated with 
the TGN (Robinson,  1987; Ahle et ai., 1988). The subunit 
composition of the plasma membrane adaptor is ot-adaptin 
+/3-adaptin +. AP50  +  AP17, while the subunit composi- 
tion of the TGN adaptor is ~-adaptin  +/~'-adaptin +  AP47 
+ AP19 (Keen, 1987; Ahle et al., 1988). In vitro studies in- 
dicate that adaptors bind not only to clathrin, but also to the 
cytoplasmic  domains  of membrane  proteins  known to be 
concentrated  in coated pits,  such as the LDL receptor  and 
the mannose-6-phosphate receptor (Pearse, 1988; Glickman 
et al., 1989). However, it seems unlikely that these interac- 
tions target the adaptors to the appropriate compartment, as 
the distribution  of such membrane  proteins  is much more 
widespread  than the disruption  of the adaptors.  Thus,  the 
mechanism whereby adaptors are recruited onto the plasma 
membrane or the TGN is still unknown. 
One approach that has been used to investigate the target- 
ing of other molecules  is the construction  of chimeras,  in 
which  domains  are  switched  between  two  proteins  with 
different destinations. Because all the adaptor subunlts have 
been cloned and sequenced, such an approach is now feasi- 
ble as a means of locating the targeting signal on the adaptor 
complex. Sequencing reveals that the/3-adaptin  subunits of 
the plasma membrane and TGN adaptors are the most ho- 
mologous, with 85 % sequence identity (Kirchhausen et al., 
1989; Pormambaiam et al., 1990). The medium chains are 
40%  identical  (Nakayama et al.,  1991), while  the  small 
chains are 45% identical (Kirchhausen et al., 1991). Least 
homology is seen between the or- and 3,-adaptins, with only 
25 % identity overall and with COOH termini that appear to 
be completely unrelated  (Robinson,  1989, 1990). 
Construction of chimeras is facilitated by our knowledge 
of adaptor structure.  The plasma membrane adaptor com- 
plex appears in the electron microscope as a brick-like core 
or "head" flanked by two smaller appendages or "ears; con- 
nected by stalks which are thought to act as flexible hinges 
(Heuser and Keen,  1988) (see the model in Fig.  8).  Con- 
trolled proteolysis  cuts at the hinges and releases the two 
ears. Sequencing of  the ear fragments has shown that the ears 
correspond to the COOH-terminal domains of the proteins, 
while  the hinges  correspond  to stretches  of ,,ol00 amino 
acids about two thirds of the way along the proteins with a 
high abundance ofproline and glycine residues (Kirchhausen 
et al.,  1989). Although the TGN adaptor complex has not 
yet been viewed by EM, its proteolytic cleavage pattern and 
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that it has a structure similar to that of the plasma membrane 
adaptor (Schroder and Ungewickell, 1991; Robinson, 1990). 
Here I report experiments in which the COOH-terminal 
ears were switched between the or- and 3,-adaptins, and were 
also completely deleted. The COOH-terminal domains of ot 
and "r were chosen for two reasons. First, because they do 
not appear to interact with the other subunits of the adaptor 
complex,  it  should be  possible  to  modify them without 
affecting adaptor assembly; and second, because of their 
lack of homology with each other, it seems likely that they 
are required for functions specific to the plasma membrane 
and TGN adaptors. The constructs were all designed to con- 
tain the bovine ~-adaptin hinge, allowing them to be detected 
with a  species-specific antibody, mab  100/3,  when trans- 
fected into Rat 1 fibroblasts, since the antibody reacts with 
the 3,-adaptin hinge from most mammals but does not recog- 
nize the rodent protein (Ahle et al., 1988; Robinson, 1990). 
The antibody proved useful both for localizing the constructs 
by immunofluorescence and for immunoprecipitating adap- 
tor complexes containing the engineered adaptins. 
Materials and Methods 
Construction of Plasmids 
Most of the DNA manipulations that were carried out followed protocols 
described by Sambrook et al. (1989).  The strategy that was adopted for the 
construction of chimeras was to introduce new restriction sites on either 
side of the hinge-encoding sequences in c~-adaptin (c¢C) and 3,-adaptin (see 
Fig.  1). The hinge was defined as amino acids 620-700 in c~ and 594-703 
in % based on the abundance of prolines and glycines in these regions and 
the optimum alignment of c¢- and 3,-adaptins.  In both proteins the hinge be- 
gins with the sequence GP and ends with the sequence PG, allowing Apal 
and SmaI sites to be introduced into the DNA without changing the se- 
quence of the protein products (see Robinson, 1989,  1990). 
Both the c~-adaptin and the 3,-adaptin  cDNAs had been subcloned into 
the EcoRl site ofpBiuescript SK-. The ~/-adaptin that was used was a mouse- 
cow chimera, joined at a PstI site near the middle of the eDNA, which con- 
rains the epitope recognized by mAb 100/3  (Robinson,  1990).  Because 
there are already endogenous Apal and Smal sites in both plasmids, it was 
first necessary to eliminate some of them. The eDNA encoding ~-adaptin 
contains an ApaI site at precisely the right position (base 1857).  There are 
two SmaI sites in the ct-adaptin plasmid that needed to be eliminated, how- 
ever: one in the 5' untranslated region and another in the polylinker of the 
vector upstream from the insert. These were removed by cutting with Smul 
and BamHI (which only cuts in the polylinker, upstream from the SmaI 
site), blunting, and religating the plasmid. The same strategy was used to 
remove SmaI sites in the 5' untranslated region and polylinker of the 3,-adap- 
tin plasmid. In addition, it was necessary to remove an ApaI site in the 3' 
untranslated region of the 7-adaptin plasmid and another ApaI site in the 
polylinker downstream from the insert. This was achieved by cutting with 
ApaI, blunting, and religation. 
New restriction sites were engineered into the constructs by oligonucleo- 
tide-directed mutagenesis.  Three  mutagenic  primers  were  synthesized: 
Oligo 1, containing one mismatch for introducing the SmaI site into c~-adap- 
tin at base 2025; Oligo 2, containing one mismatch for introducing the ApaI 
site into ~/-adaptin at base 1779; and Oiigo 3, containing three mismatches 
for introducing the SmaI site into ,,/-adaptin  at base 2104.  The sequences 
of the three oligonucleotides are shown below: 
Oligo 1" TTGCACCCCJC~TCTGAAGACA 
Oligo 2: AGTGACCACAAA~CCTACTGAG 
Oligo 3: AATGACAT'IGCTCCCGC~ATCCCCTCCATC 
Single-stranded DNA was prepared either by using the helper phage K07 
(for introducing the SmaI site into 3,-adaptin)  or by subcloning into M13, 
using a SacI-ECORI fragment for -y-adaptin and a KpnI fragment for ~-adap- 
tin, both of which contained the region to be mutagenized (see Fig. 1). The 
mutagenic primers were annealed to the single stranded DNA and second 
strands were synthesized, ligated, and used to transform TG2  host cells. 
Mutant colonies or plaques were identified by hybridizing with the muta- 
genic oligonncleotides at different stringencies and were sequenced to check 
that the correct mutations had been engineered into the constructs. In addi- 
tion, most of the rest of the DNA was re-sequenced to ensure that no errors 
had been introduced when the second strand was copied. The two fragments 
were then religated back into the original plasmids to create plasmids ~AS 
and p'yAS (see Fig.  1). 
To construct the chimera "r'yc~, plasmids lYyAS and po~AS were cut with 
EcoRI, which cuts near the 3' end of the insert in p'yAS and in the polylinker 
downstream from the insert in Ix~AS, and SmaI, and the insert from pcxAS 
was ligated into the p-yAS vector. The chimera cey-r was made by cutting 
p~AS and potAS with NotI, which cuts in the polylinker upstream from the 
insert in both plasmids, and ApaI, after which the insert from pc~AS was 
ligated into the p/AS vector. The chimera c~.yc~  was constructed by cutting 
the plasmid containing cq,'y and pc~AS with Sinai and EcoRI and inserting 
the insert from tx~AS into c~/3~. 
The chimeras were then subcloned into pHYKS3 (Robinson, 1990),  an 
expression vector containing the SV-40 early promoter and a polylinker 
with unique cloning sites for HindIII, BglII, NotI, KpnI, and EcoRI. NotI 
and EcoRI were used to make the expression plasmids ly,/~/c~  and pc~q~c~. To 
construct the expression plasmid P~'r'/, the insert needed to be moved in 
two pieces because of the presence of an endogenous EcoRI site in the cod- 
ing region and the destruction of the EcoRI site in the polylinker. First a 
5' NotI-KpnI fragment was subcloned, followed by the 3' KpnI fragment 
(see Fig.  1).  The ear deletion constructs were prepared from p~3,c~ and 
p"/3,c~ using Oligo 4, a double stranded oligonucleotide containing a stop 
codon and an EcoRI site: 
Oligo 4: GGGTAGGAATTCCTACCC 
The oligonncleotide was annealed to itself (not that it is a palindrome), 
kinased, and ligated into pc~3,c~  and p"/3'cq both of which had been cut with 
SmaI and phosphatased, to make P~3'- and P'g3'-. Aliquots of the plasmids 
were cut with EcoRI to ensure that the double stranded oligonucleotide had 
been successfully ligated. 
Transfection  into Rat 1 Cells 
Rat 1 fibroblasts in culture were transfected with all the above constructs 
by  the calcium phosphate method,  as previously described (Robinson, 
1990).  Transiently expressing cells were examined 2 daRer transfection. 
To make stable transfectants, the cells were co-transfected with the adaptin 
chimeras and pRSVneo, a  plasmid containing the G418  resistance gene 
downstream from the RSV promoter, constructed and generously provided 
by P. Goodell (MRC Laboratory of Molecular Biology, Cambridge, En- 
gland). After 2 d in culture, the cells were trypsinized and plated into three 
9-cm-diam tissue culture dishes for each 25-cm  2 flask. On day three, (;418 
was added at a concentration of 0.5 mg/ml. Medium containing 0.5 mg/mi 
G418  was changed every 3 d. After 2 wk, individual G418-resistant colo- 
nies were picked with sterile yellow tips and transferred to multiwell plates. 
Expression of adaptins was assayed by immunofluorescence (see below). 
Detection of Constructs with mAb 100/3 
Immunofluorescence. Cells on multiwell test slides were fixed in methanol 
and acetone, as previously described (Robinson, 1990).  Immunofluores- 
cence was carried out using the mouse anti-3,-adaptin antibody mAb 100/3 
(Ahle et al., 1988),  and some cells were double labeled with either a rabbit 
antiserum against TGN38 (Luzio et al.,  1990)  or antibody C8.  Antibody 
C8 is a rabbit antiserum raised against a pGEX fusion protein containing 
part of the hinge region of c~C (amino acids 619-656) and absorbed with 
a  fusion protein containing the comparable part  of c~A before aliinity 
purification to make it monospecific  (Ball, C. L., and M. S. Robinson, manu- 
script in preparation). Antibody incubations, labeling with secondary anti- 
bodies, mounting, and examination of the slides were all carried out as pre- 
viously described (Robinson, 1990). 
Western Blotting. Stably transfected cells were grown in 9-cm-diam 
dishes until confluent, and similar cultures were prepared for Vero cells 
(positive control) and nontransfected Rat 1 cells (negative control and posi- 
tive control for endogenous c~-adaptin). Two dishes were pooled for each 
cell line. The cells were trypsinized, washed, and resuspended in 150 ~1 
lysis buffer (Buffer A  [0.1 M  MES,  pH  6.5,  0.2  mM EGTA,  0.5  mM 
MgC12, 0.02%  NAN3] containing 1% NP-40, 10 mg/ml BSA, 1 mM PMSF, 
0.4 mg/mi BPTI, 1 ~g/mi leupeptin, and 1 ~tg/ml pepstatin). After a 5-rain 
incubation at room temperature, the ceils were spun at 50,000 RPM for 15 
rain  in  a  Beckman  micro-ultracentrifuge (Beckman  Instruments,  Inc., 
Fullerton, CA). The pellets were resuspended in the same volume of lysis 
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ume of 2 x  SDS-PAGE and sonicated before being subjected to SDS-PAGE. 
Gels were blotted onto nitrocellulose and labeled either with mAb 100/3 
followed  by rabbit anti-mouse IgG and  125I-protein A  (for endogenous 
3,-adaptin  and the constructs), or with mAb AC1-Mll  followed by IzsI- 
protein A (for endogenous o~-adaptin), as previously described (Robinson, 
1987; Robinson and Kreis,  1992). 
lmmunoprecipitation.  The immunoprecipitation  protocol was based on 
a method developed by B. Pearse (personal communication), which involves 
extracting a  high speed pellet of detergent-lysed  ceils with Na2CO3 and 
then precipitating adaptors from the extract. Three 9-cm-diam dishes of 
confluent cells were used for each stably transfected cell line and for the 
positive and negative controls (see above). The cells were grown overnight 
in 15 ml methionine-free medium per dish, containing 3% dialyzed  FCS 
and 20 #Ci/ml Tran35S Label (Amersharn International, Amersham, UK). 
The following  morning, the cells were trypsinized, pooled, washed,  and 
resuspended in 300/~1 lysis buffer. After a 5-rain incubation at room temper- 
ature, the cells were spun 5 rain in a microfuge and the supernatants were 
then spun at 50,000 RPM for 15 min in a Beckman micro-ultracentrifuge. 
Pellets from this step were resuspended in 150 #1 lysis buffer to which 7.5 
/~1 1 M Na2CO3 was then added.  After a 5-min incubation on ice, the sam- 
pies were spun at 50,000 RPM for 15 rain in the micro-ultracentrifuge, after 
which the supernatants were incubated on ice with 7.5 pl 1 M KH2PO4 for 
I h. These samples were then spun at 70,000 RPM for 20 rain in the micro- 
ultracentrifuge. Supernatants were mixed with an equal volume of lysis 
buffer, and 100 #1 aliquots were incubated with 2/~1 mAb 100/3 (the anti- 
body concentration had been estimated to be 0.5 mg/ml). After a 1-h incuba- 
tion at room temperature, the samples were spun for 5 rain in a microfuge, 
and the supernatants were incubated for a further 10 min with 0.3/~1 rabbit 
anti-mouse  IgG  (Sigma  Immunocbemicals,  St.  Louis,  MO).  Protein 
A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) (30 td of a 50% 
slurry) was then added and the samples were incubated for another hour. 
All incubations involving  antibodies were carried out on a  rotator.  The 
Sepharose was then pelleted by a 1-min spin in the microcentrifuge, and the 
pellets were extensively washed: first 3× in 0.15 M NaC1, 50 m_M Tris, pH 
8.2, 2 mM EDTA, and 0.2%  NAN3, containing the same concentrations of 
NP-40,  BSA,  and protease inhibitors as the lysis buffer;  then 3×  in the 
above solution but with 0.5 M NaCI; and finally 2× in the high NaC1 buffer 
but without the extra additions. The final pellets were resuspended in 15 
t~l  2×  sample buffer,  boiled,  and subjected to  SDS-PAGE.  Gels were 
fluorographed, dried down, and autoradiographed. 
Immunopreeipitation was also carried out on the high speed superna- 
tants. Although the samples were heavily contaminated with additional pro- 
teins (also seen in the negative control lane), for each cell line the ratios 
of  the  adaptin  constructs  to  the  other  adaptor  subunits  in  the  im- 
munopreeipitates from the high speed supernatants appeared to be similar 
to  the  ratios in the immunoprecipitates from the extracted high speed 
pellets. 
Results 
Localization of  adaptin Constructs 
To investigate the possible role of the c~- and -y-adaptin ears 
in adaptor targeting, new restriction sites were engineered 
into both adaptin cDNAs on either side of  the hinge, allowing 
the hinges and/or ears to be either exchanged between the 
two proteins or deleted (Fig.  1). The nomenclature for the 
constructs  refers  to  their  three  domains:  NH2  terminus, 
hinge,  and ear.  All of the constructs contain the bovine 
7-adaptin hinge to enable them to be detected by mAb 100/3, 
a  species-specific antibody that recognizes the hinge region 
of the protein but does not react with endogenous 3,-adaptin 
in rodent cells (Able et al.,  1988;  Robinson, 1990). 
Rat  1  fibroblasts  were  transfected  both  with  normal 
-y-adaptin and with the five new constructs, and were exam- 
ined by immunofluorescence. The distribution of the con- 
structs was first studied in transiently expressing cells, but 
because the transfection efficiency was low,  stably trans- 
fected cells were generated by co-transfecting with a plasmid 
containing the G418 resistance gene. Although some of the 
cell lines showed heterogeneous patterns of expression, it 
was possible to obtain lines for all of the constructs in which 
the majority of the cells were expressing at comparable lev- 
els.  Fig.  2  shows  immunofluorescence staining of Rat  1 
fibroblasts stably transfected with the normal "y-adaptin con- 
struct (Fig. 2 a) and the constructs 3'~a (Fig. 2 b) and ~3'- 
(Fig. 2  c), double labeled with a  rabbit antiserum against 
TGN38 (Fig. 2, d-f), an integral membrane protein of the 
"I'GN (Luzio et al., 1990).  Normal "y-adaptin (Fig. 2 a) has 
a  perinuclear  distribution  in  the  cell,  similar  to  that of 
TGN38 (Fig. 2 d), but more punctate and extending to more 
peripheral regions of the cell. This is the same sort of label- 
ing that is seen in ceils stained for endogenous 3,-adaptin (see 
Ahle et al.,  1988;  Robinson,  1990). 
Fig. 2 b shows the distribution of the construct "y3,c~, con- 
taining the 3,-adaptin NH2 terminus and hinge, but with the 
c~-adaptin ear. The distribution of the construct is very simi- 
N terminus  hinae  ear 
A~  EcoRI  K~nl  Notl  K~nl  I  Smal 
p(zAS  f=  ~  =f 
8a61 Nell  Pstl  Apal  8malEcoRI  K~nl 
7Tcx 
77- 
~TT 
~/- 
I  m~  I 
I  1~.6~.! 
Figure  1.  Construction  of 
adaptin chimeras. Oligonucle- 
otide-directed  mutagenesis 
was  used  to  introduce  ApaI 
and SmaI sites on either side 
of  the  hinge  in  the  c¢-  and 
3'-adaptin cDNAs.  The resul- 
tant  plasmids,  I~AS  and 
p3,AS, were cut and re-ligated 
to produce the five new con- 
structs: 3'3,0~, 3'3"-, ccyot, ot3'3', 
and  c~3,-. The  nomenclature 
refers  to  the  three  domains, 
NH2  terminus,  hinge,  and 
ear;  c~  sequences  are  white 
and 3' sequences are stippled. 
All the restriction sites shown 
in  the  figure  were  used  for 
subcloning and are mentioned 
in the text. 
Robinson Assembly and Targeting of Adaptin Chimeras  69 Figure 2. Immunofluorescence localization of constructs containing the 3'-adaptin NH2 terminus, double labeled for TGN38. Stably trans- 
fected Rat 1 ceils were double labeled with mAb 100/3 (a-c) and an antibody against TGN38 (d-f). The cells in a and d were transfected 
with normal 3"-adaptin containing the epitope recognized by mAb 100/3, b and e with 3'3'a, and c and fwith 3'3'-. All of the constructs 
are targeted to the TGN. Bar, 20 #m. 
lar to that of normal -¢-adaptin, although careful examination 
of the cells suggests that there may be a slight increase in the 
relative amount of cytoplasmic and/or peripheral staining. 
In Fig. 2 c, the localization of the ear-minus ~/-adaptin con- 
struct, "Y3'-,  is shown. There is a marked increase in the rela- 
tive amount of cytoplasmic staining when compared with the 
other two constructs.  This is not related to the level of ex- 
pression of the construct:  in both high-expressing and low- 
expressing cell lines, the amount of cytoplasmic staining rel- 
ative to perinuclear staining is consistently much higher than 
in cells expressing either "t or 3,3,ct. Nevertheless, the label- 
ing pattern indicates that at least some of the truncated pro- 
tein is associated with the TGN compartment. Thus, all of 
the constructs containing the 3,-adaptin NH~ terminus and 
hinge are able to be correctly targeted to the TGN. 
The localization of the construct otTa, which contains the 
t~-adaptin  NH2  terminus  and  ear,  but  with  the  ,y-adaptin 
hinge, is shown in Fig. 3 a. Numerous dots are seen extend- 
ing out to the cell periphery, often aligned in rows. There is 
no apparent concentration of the label in the Golgi region 
(see Fig. 3 d), and focusing up and down on the cells indi- 
cates that the dots are in the plane of the plasma membrane. 
Thus, ot,yot  has a similar distribution to that of endogenously 
expressed wild-type ot-adaptin (see Robinson,  1987),  indi- 
The Journal of Cell Biology, Volume 123, 1993  70 Figure 3. Immunofluorescence localization of constructs containing the c~-adaptin  NH2 terminus, double labeled for TGN38. Stably trans- 
fected Rat I cells were double labeled with mAb 100/3 (a-c) and an antibody against TGN38 (d-f). The cells in a and d were transfected 
with ot'Vx,  b and e with wy3,, and c andfwith cO,-. All of the constructs show punctate labeling extending out to the cell periphery without 
any obvious colocalization with TGN38, indicating that they are able to be targeted to the plasma membrane, although ¢x~,~, shows increased 
cytoplasmic  staining and -3'- appears to be predominantly  cytoplasmic  (especially in the upper two cells).  Some non-expressing cells 
are seen in c. Bar, 20 #m. 
cating that replacing the ot-adaptin hinge with the 3,-adaptin 
hinge does not affect the localization of the protein. 
When  the  ,y-adaptin ear  is  transplanted  onto  ot-adaptin 
(Fig. 3 b), the staining pattern looks somewhat different from 
that of the endogenous protein or of ot,yot. Increased cyto- 
plasmic staining  is  seen,  particularly  around the  nucleus. 
However, when the cells are double labeled for TGN38 (Fig. 
3 e), the construct does not appear to be especially concen- 
trated in the Golgi region: the TGN38 labeling tends to be 
on one side of the nucleus,  while the ot~,3, labeling is more 
uniformly distributed and probably reflects an increase in the 
cytoplasmic pool of the protein which accumulates where 
the cell is thickest. 
A  larger increase in the  relative amount of cytoplasmic 
staining is seen in cells expressing the ear-minus construct 
ix'y- (Fig. 3 c). These cells tended to be somewhat heteroge- 
neous in their labeling patterns, but in most of  them a charac- 
teristic ot-adaptin staining pattern can be seen (e.g.,  in the 
lower cell in Fig. 3 c), although it is often obscured by the 
cytoplasmic staining  (e.g.,  in the upper cells in Fig.  3  c). 
Robinson Assembly and Targeting of Adaptin Chimeras  71 Figure 4. Immunoflourescence localization of constructs containing the c~-adaptin NHz terminus, double labeled for endogenous ¢-adap- 
tin. Stably transfected Rat 1 cells were double labeled with mAb 100/3 (a-c) and an antibody that recognizes only endogenous c~-adaptin 
(d-f). The ceils in a  and d were transfected with c¢-/c~, b and e with c~/3,, and c and f  with c¢7-. The fluorescent dots labeled with the 
two antibodies coincide (a particularly well spread cell is shown in c, so the characteristic cytoplasmic distribution of c~/- is less apparent). 
Thus,  all the constructs with the c~-adaptin NH2 terminus are able to be incorporated into plasma membrane coated pits.  Some non- 
expressing cells are seen in b  and c. Bar, 20/zm. 
Thus,  although much of the labeling is cytoplasmic, a  frac- 
tion  of the  construct  appears to be capable of associating 
with the plasma membrane. 
Colocalization with Endogenous ~-Adaptin 
To confirm that the constructs  ~3,0~, ot3,'y, and  ~3'- are as- 
sociated with plasma membrane coated pits, cells were dou- 
ble labeled for endogenous o~-adaptin. This was achieved by 
using a  rabbit antibody raised against a  fusion protein con- 
taining the ot-adaptin hinge, which does not cross react with 
any  of the  constructs  since  they  all  contain  the  ~/-adaptin 
hinge (see Fig. 1). Fig. 4 shows the three cell lines expressing 
constructs  containing  the o~-adaptin NH~ terminus  (Fig.  4, 
a-c), double labeled with the antibody against endogenous 
ot-adaptin  (Fig.  4,  d-f).  In  all  cases,  the  fluorescent  dots 
coincide,  confirming that these constructs are correctly tar- 
geted to the plasma membrane and incorporated into coated 
pits. 
Because the cells expressing ,y-adaptin NH2-terminal con- 
structs  always  show  a  certain  amount  of punctate  labeling 
which does not coincide with TGN 38, these cells were also 
double  labeled  for  endogenous  o~-adaptin  to  see  whether 
there was any colocalization.  As shown in Fig. 5, there is no 
The Journal of Cell Biology, Volume 123, 1993  72 Figure 5. Immunofluorescence localization of constructs containing the 7-adaptin  NH2 terminus, double labeled for endogenous ct-adap- 
tin.  Stably transfected Rat 1 cells were double labeled with mAb 100/3 (a-c) and an antibody against endogenous ct-adaptin (d-f). The 
cells in a  and d were transfected with normal 7-adaptin,  b and e with 3,7ct, and c and fwith 3'7-. Although neither normal 7-adaptin 
nor 77- coincides  with ct-adaptin, a small amount of 73,ct shows colocalization,  indicated by the arrowheads.  Bar, 20 #m. 
obvious colocalization of either normal 7-adaptin or the con- 
struct 3'7- with c~-adaptin  (Fig. 5,  compare a  with d, and c 
with f).  However, in some of the cells expressing the con- 
struct  with  the  ot-adaptin  ear,  77a,  there  is  significant 
colocalization with endogenous ct-adaptin at the cell periph- 
ery, marked with arrowheads. Thus, although this construct 
is predominantly perinuclear, in some cells a small fraction 
of the protein appears to be associated with plasma mem- 
brane coated pits. 
Solubility of the Constructs 
To test  whether  the  increased  cytoplasmic localization  of 
some of the constructs could be correlated with an increase 
in their solubility, Western blots were carried out on cells 
that had been extracted with 1% NP-4-0, then pelleted at high 
speed.  Fig.  6  shows blots of the  supernatants  and pellets 
(made up to the same volume) of all 6 cell lines probed with 
mAb 100/3,  together with positive control lanes containing 
Vero cells (which express endogenous 7-adaptin that reacts 
with the antibody),  negative control lanes containing non- 
transfected Rat  1 cells,  and  lanes  containing  supernatants 
and pellets from non-transfected Rat 1 cells labeled for en- 
dogenous ot-adaptin (o0. All of the constructs migrate with 
approximately their expected mobilities, since the 7-adaptin 
ear is nearly twice the size of the 7-adaptin ear (see Fig.  1). 
However, when constructs with the same ear are compared, 
those with the 7-adaptin NH2 terminus consistently migrate 
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transfected cell extracts. Cells were extracted with 1% NP-40 and 
centrifuged at high speed, and both the supernatants and the pellets 
(made  up to equal  volumes)  were  subjected  to SDS-PAGE and 
Western  blotting.  All the lanes  except the  ones  marked c~ were 
probed with  mAb 100/3;  the  c~ lanes  containing  nontransfected 
cells probed with the anti-c~-adaptin mAb AC1-M11. The positive 
control lane contains Vero cells, the negative control lane contains 
non-transfected Rat 1 ceils, and the other six lanes contain the cell 
lines shown in Figs. 2-5. The constructs that show increased cyto- 
plasmic  staining by immunofluorescence also appear to be more 
soluble. 
slower than those with the ot-adaptin NH~ terminus (com- 
pare 3' with t~3'3", 3'3"c~  with c~3"ot, and 3'3'- with ct'y-), in spite 
of the fact that the ot-adaptin NH2-terminal domain is some- 
what larger than the 3'-adaptin NH2-terminal domain (see 
Fig. I). Since endogenous 3"-adaptin migrates with an appar- 
ent molecular mass of 95-100 kD, while its actual molecular 
weight (determined from its amino acid sequence) is 91,352 
(Robinson, 1990), these observations indicate that the anom- 
alous  migration of 7-adaptin  is a  function of its  NH2 ter- 
minus. 
A comparison of the relative intensity of labeling in the su- 
pernatant and pellet lanes for endogenous 3"- and o~-adaptins 
indicates that very little of the 7-adaptin is soluble,  while 
nearly half of the c~-adaptin  is soluble. Quantification of the 
autoradiographs by densitometry revealed that in this experi- 
ment, 8 % of the 3"-adaptin  signal was found in the superna- 
rant and 36% of the ¢x-adaptin signal. The normal 3"-adaptin 
construct and the construct 77ol are both found mainly in the 
pellet, although both are more soluble than the endogenous 
protein (23 and 33 % of the signal, respectively), possibly be- 
cause they are expressed at somewhat higher levels. In con- 
trast, the ear-minus construct, 3'3"-, is more concentrated in 
the supernatant  (66%),  consistent with its increased cyto- 
plasmic staining by immunofluorescence (see Figs. 2 and 5). 
Of the  constructs  with  the  ~x-adaptin  NH2-terminus,  the 
solubility of cx3'cx appears to be similar to that of endogenous 
a-adaptin  (32%),  while  o~3"3' is  somewhat  more  soluble 
(56%) and ~x3"- is much more soluble (92%).  These results 
are also consistent with the immunofluorescence data. Thus, 
the tendency of some of the constructs to accumulate in the 
cytosol can be demonstrated by Western blotting as well as 
immunofluorescence. 
Figure 7.  Immunoprecipitation  of adaptor complexes containing 
adaptin chimeras. Extracts from the cell lines shown in Fig. 6 were 
immunoprecipitated  with mAb 100/3 under nondenaturing condi- 
tions. The band that is recognized by the antibody (either endoge- 
nous 7-adaptin  or a construct) is indicated in each of the lanes by 
an arrowhead. The bands marked with dots are the other subunits 
of the adaptor complex which co-precipitate:  either/~',  AP47, and 
API9 in the positive control,  7, 73,c~, and 37- lanes; or/~, APS0, 
and API7 in the c~'rc~, c~77, and c~3,- lanes. Because the c~3,, con- 
struct and ~-adaptin have virtually  identical mobilities in this gel 
system, the two proteins cannot be resolved in the a3" lane. Other 
bands that are present in the lanes appear to be contaminants: rela- 
tive amounts of  them varied from one sample to another, even from 
the  same  cell  line;  and  they  could  also  be  detected  in  non- 
transfected cells and in controls from which the first antibody had 
been omitted. 
Assembly of  Adaptor Complexes 
To investigate whether the constructs are capable of assem- 
bling into adaptor complexes, immunoprecipitation of ex- 
tracts  from 35S-labeled  cells  was  carried  out  under  non- 
denaturing conditions (Fig. 7). In the positive control lane, 
a Vero cell extract precipitated with mAb 100/3  is shown. 
It  is  clear  that  the  antibody  has  brought  down  not  only 
7-adaptin  (arrowhead), but  also  ~'-adaptin,  AP47,  and 
AP19  (indicated  with dots). None of these bands are seen 
in the negative control lane containing non-transfected Rat 
1 cells immunoprecipitated with mAb  100/3,  while all of 
them are seen in the  lane containing  the precipitate from 
cells transfected with normal 7-adaptin.  In contrast to the 
positive control lane, however, in this lane the other adaptor 
subunits appear to be substoichiometric with 7-adaptin, pre- 
sumably because the 7-adaptin DNA is coupled to a strong 
constitutive promoter and thus is somewhat overexpressed. 
The same three bands can be seen in the lanes containing 
immunoprecipitates of extracts from cells expressing 73,c~ 
and 77-. 
In the other three lanes,  which contain immunoprecipi- 
tates  from cells  expressing  constructs  with the  ct-adaptin 
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Figure 8. Models of the adap- 
tor complexes  assembled from 
wild-type or engineered adap- 
tins. Proteins normally found 
in the Golgi adaptor complex 
are stippled;  those  normally 
found  in  the  plasma  mem- 
brane  adaptor  complex  are 
white; and chimeras are indi- 
cated accordingly. The mem- 
branes with which the various 
adaptor  complexes associate 
are indicated. 
NH2 terminus,  the three co-precipitating bands are differ- 
ent. In place of the/~' band, there is a slightly faster migrating 
band, presumably fl-adaptin which runs somewhat ahead of 
fl' (see Ahle et al.,  1988). The AP47 band has disappeared, 
and there is a new,  somewhat slower migrating band, pre- 
sumably AP50. At the bottom of the gel, the AP19 band can 
no longer be seen and a new band is apparent, which has the 
expected mobility for AP17. 
Thus, in spite of the changes that have been engineered 
into the COOH-terminal ear domains, all of the constructs 
with the "r-adaptin NH2 terminus appear to be capable of 
assembling into Golgi adaptor complexes, while all of the 
constructs with the oz-adaptin  NH2 terminus appear to be 
capable of assembling into plasma membrane adaptor com- 
plexes; and these complexes are able to be targeted to the 
appropriate  membrane.  These  results  are  summarized  in 
Fig.  8. 
Discussion 
The results presented in this study indicate that the a- and 
q/-adaptin  ears are not required for adaptor targeting. This 
raises two questions: first, what is the function of the ears 
if not targeting; and second, where is the targeting informa- 
tion if not in the ears? 
A potential insight into the function of  the ears comes from 
the observation that the ear-minus or- and 3,-adaptins  show 
relatively more cytoplasmic staining than either wild-type or 
ear-swapped  constructs.  Similarly,  Western  blots  of high 
speed supernatants and pellets from extracts of transfected 
cells reveal that the ear-minus constructs are more soluble. 
Thus, without their ears, the proteins appear to be impaired 
in their ability to attach to membranes and/or to be incorpo- 
rated  into  coated pits.  One  possible  explanation  for this 
finding might be that the ear-minus constructs are simply 
misfolded; however, the immunoprecipitation experiments 
indicate that the truncated adaptins are fully capable of as- 
sembling  into  adaptor complexes.  Alternatively,  the  ears 
could stabilize the association of adaptor complexes with the 
membrane:  for instance, they could participate in clathrin 
binding, in the binding of adaptors to the cytoplasmic tails 
of selected membrane proteins, or in adaptor-adaptor inter- 
actions. 
A number of experiments have been carried out using pro- 
teolytically cleaved adaptors to assess the potential role of 
the adaptor ears in clathrin binding and assembly. Results of 
these studies show that earless adaptors are unable to pro- 
mote clathrin assembly in solution (Schroder and Ungewick- 
ell, 1991). However, there is some evidence that the ears do 
not interact directly with clathrin: plasma membrane adap- 
tor heads alone are able to bind to preformed clathrin cages 
(Keen and Beck, 1989); proteolysis of coats assembled from 
clathrin plus adaptors results in the release of the ears while 
the heads stay behind with the clathrin (Matsui and Kirch- 
hausen,  1990);  and clathrin can co-assemble with proteo- 
lyzed adaptors on exposed plasma membranes (Peller et al., 
1993). Certainly the lack of homology between the or- and 
3,-adaptin  ears  tends  to  argue  against  a  role  in  clathrin 
binding. 
However, this lack of homology is an argument in favor of 
the idea that the ears may bind to the cytoplasmic tails of 
membrane proteins, since the signals that direct membrane 
proteins  into  coated  pits  on  the  plasma  membrane  are 
thought to be different from the signals that direct them into 
coated pits in the TGN (Lobel et al., 1989). Although so far 
the  only  published  experiment  addressing  this  question 
failed to  show  any  interaction between adaptor ears  and 
membrane protein tails,  the study was done using proteo- 
lyzed adaptors immobilized on a Western blot (Beltzer and 
Spiess, 1991), and it is possible that the ears need to be cor- 
rectly folded for binding to occur. One attraction of the ear- 
tail interaction model is that the flexible hinges would allow 
the ears to make contact with internalization or sorting sig- 
nals which can be either very close to the membrane or a 
considerable distance away (Trowbridge, 1991). Although it 
seems unlikely that this interaction is what directs the adap- 
tors to the appropriate membrane, it is possible that once the 
adaptors are membrane bound, they make contact with the 
cytoplasmic tails of other proteins in the same compartment 
and that this interaction may help to anchor them onto the 
membrane. Thus, deleting the ears might result in a less sta- 
ble association of adaptors with the membrane, while swap- 
ping the ears between o~- and "r-adaptins might cause the 
adaptors to bind to a different set of membrane proteins. 
Another possibility is that the ears might participate in in- 
teractions between  adaptor  complexes of the  same  type. 
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in vitro and although this process seems mainly to occur via 
the heads (Beck and Keen, 1991), it is possible that the ears 
may also be involved.  If so, this might explain both the in- 
creased cytoplasmic distribution of the ear-minus constructs 
and the observation that a small amount of the construct 7-yoe 
is associated with plasma membrane coated pits: Golgi adap- 
tors with one ot-adaptin  ear might interact to some extent 
with plasma membrane adaptors and thus be incorporated 
into coated pits assembling on the plasma membrane. One 
way to find out more about the function of the ears might be 
to overproduce the ear-minus and ear-swapped constructs to 
such high levels that virtually all of the adaptor complexes 
would contain mutant rather than endogenous adaptins, and 
then to study the phenotype of the transfected ceils further 
(e.g., whether they are defective in receptor-mediated en- 
docytosis or sorting at the TGN). 
So far only one other study has been carried out to address 
the question of whether the adaptin ears are involved in the 
association of adaptors with the membrane. Purified plasma 
membrane adaptors had previously been shown to be able 
to bind to the exposed cytoplasmic surface of the plasma 
membrane in sonicated ceils (Mahaffey et al.,  1990),  and 
this interaction is still able to occur after removal of the 
ol- and ~-adaptin ears by proteolysis (Peeler et al.,  1993). 
These results are largely in agreement with the results de- 
scribed here, except that the authors did not find that the ear- 
less adaptors were in any way impaired in their ability to as- 
sociate  with  the  plasma  membrane.  It  is  possible  that 
adaptors assembled de novo from ear-minus oe-adaptin may 
behave somewhat differently from pre-assembled adaptors 
from which the ears are then removed. Moreover, the in vitro 
system used by Peeler et al. (1993) is designed to study the 
ability of adaptors to bind to sites previously occupied by en- 
dogenous adaptors, while the in vivo results reflect the distri- 
bution of adaptors at steady state, where other interactions 
may be involved. 
The second question raised by this study concerns the na- 
ture of  the targeting signal on the adaptor complex. Although 
the partial colocalization of the construct -Vyot with endoge- 
nous ot-adaptin suggests that there may be multiple targeting 
signals, it is clear that the contribution of the or- and 3,-adap- 
tin ears to adaptor targeting is at most a very minor one, and 
possibly a passive one. The hinges are unlikely to play any 
role in adaptor targeting since the 3,-adaptin hinge does not 
affect  the localization of ot-adaptin; indeed, the hinge appears 
to be the least conserved domain when adaptin isoforms of 
the same class are compared (Robinson, 1989; Kirchhausen 
et al., 1989), and it may simply need to be present as a flexi- 
ble connection between the head and ear. 
Thus, the NH2-terminal domains of the o~- and 3,-adaptins 
appear to determine whether the proteins associate with the 
plasma  membrane  or  the  TGN.  However,  this  does  not 
necessarily imply that there is actually a targeting signal in 
the  NH2-terminai domain:  because  all the constructs as- 
semble into adaptor complexes, the signal could be present 
in one of the other subunits. The fl-adaptins are perhaps the 
least likely candidates for proteins containing the targeting 
signal since they are highly homologous in the two adaptor 
complexes and have already been assigned a role in clathrin 
binding (Ahle and Ungewickell, 1989).  However,  the func- 
tions of the medium and small chains, which are <50% iden- 
tical in the two complexes, are still completely unknown. By 
constructing chimeras between AP50 and AP47 and between 
AP17 and AP19,  as well as between the NH2-terminal do- 
mains of c~- and 3,-adaptins,  it should be possible to inves- 
tigate the potential role of  these other proteins in adaptor tar- 
geting. 
There is much that is not understood about how adaptors 
are recruited from the cytoplasm onto the appropriate mem- 
brane. Presumably there are special adaptor receptors on the 
plasma membrane and the TGN, which may correspond to 
the protease-sensitive factors shown to be required for the 
membrane  association of plasma  membrane  adaptors  in 
vitro (Mahaffey et al., 1990; Peeler et al., 1993).  However, 
such receptors do not have to be stoichiometric with the 
adaptors nor do they need to be incorporated into coated 
vesicles: binding could be transient, and the association of 
adaptors with the membrane could then be  stabilized by 
binding to the cytoplasmic tails of membrane proteins or 
possibly by interacting with lipids. Recent experiments mak- 
ing use of in vitro systems have shown that the recruitment 
of coat proteins onto the membrane is a complex process, 
and one that is likely to be an important regulatory step in 
the control of vesicular traffic, both clathrin mediated and 
non-clathrin mediated (Donaldson et al.,  1991; Robinson 
and Kreis, 1992; Wong and Brodsky, 1992;  Seaman et al., 
1993). By extending the in vivo approach described here to 
investigate  the  localization  of  other  chimeric  adaptor 
subunits, and by using in vitro approaches to find compo- 
nents of the cellular machinery involved in adaptor recruit- 
ment, it should be possible not only to identify the targeting 
signal on the adaptor complex, but also to learn how that sig- 
nal functions. 
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